NCT02223923View on ClinicalTrials.gov

Phase I Study to Assess Safety of AZD6738 Alone and in Combination With Radiotherapy in Patients With Solid Tumours

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Solid Tumour Refractory to Conventional Treatment
Interventions
DRUG

AZD6738

RADIATION

Palliative radiotherapy

Trial Locations (3)

NW1 2BU

University College Hospital, London

SE1 9RT

Guys and St Thomas' NHS Foundation Trust, London

SW3 6JJ

Royal Marsden Hospital, London

Sponsors
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Cancer Research UK

OTHER

collaborator

RM/ICR Biomedical Research Centre

UNKNOWN

lead

Royal Marsden NHS Foundation Trust

OTHER